Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
GO_Biological_Process_2021,Longevity regulating pathway,8/102,0.00031255098070696104,0.0350083781642434,0,0,5.109515729017099,41.2375881185493,HDAC2;ADCY9;RHEB;CREB3L2;TSC2;PRKACA;SOD1;HSPA1A
GO_Biological_Process_2021,Hedgehog signaling pathway,6/56,0.00033341312537374726,0.0350083781642434,0,0,7.176585365853659,57.45666262205517,CSNK1A1;SUFU;GPR161;CSNK1D;PRKACA;CSNK1G2
GO_Biological_Process_2021,Proteoglycans in cancer,10/205,0.0024273327433004,0.1583647718281317,0,0,3.081829692940804,18.55558027595088,VAV3;PPP1CB;PPP1CC;TGFB2;CTSL;CAV2;TWIST2;PDCD4;TWIST1;PRKACA
GO_Biological_Process_2021,Gap junction,6/88,0.0035673297185537,0.1583647718281317,0,0,4.368828078524688,24.622443925733627,GJA1;TUBA1A;ADCY9;CSNK1D;PRKACA;PRKG1
GO_Biological_Process_2021,Adrenergic signaling in cardiomyocytes,8/150,0.0037705898054317,0.1583647718281317,0,0,3.3740603127970274,18.82902402225365,PPP1CB;PPP1CC;ADCY9;CREB3L2;CACNA2D3;CREM;ATP2B4;PRKACA
GO_Biological_Process_2021,Amphetamine addiction,5/69,0.005919847185409,0.2071946514893156,0,0,4.654730243161095,23.876181113627307,PPP1CB;PPP1CC;HDAC2;CREB3L2;PRKACA
GO_Biological_Process_2021,Vascular smooth muscle contraction,7/133,0.00705737037739,0.2117211113217013,0,0,3.3197417601087325,16.444947540146526,PPP1CB;ACTA2;PPP1CC;ADCY9;MYH11;PRKACA;PRKG1
GO_Biological_Process_2021,Vibrio cholerae infection,4/50,0.009620517824292,0.2489971116200704,0,0,5.169960474308301,24.00855810959043,ATP6V1G1;ADCY9;ATP6V1E1;PRKACA
GO_Biological_Process_2021,cAMP signaling pathway,9/216,0.0106713047837173,0.2489971116200704,0,0,2.603210702341137,11.819089254233193,VAV3;PPP1CB;RAP1B;PPP1CC;ADCY9;CREB3L2;PDE4B;ATP2B4;PRKACA
GO_Biological_Process_2021,mTOR signaling pathway,7/154,0.015021742548359,0.3154565935155404,0,0,2.8424348332605214,11.93327086751244,ATP6V1G1;SEC13;RHEB;TSC2;SLC38A9;ATP6V1E1;LPIN1
GO_Biological_Process_2021,Platelet activation,6/124,0.0179272061405009,0.3211739035781087,0,0,3.030384456386937,12.186496613077267,PPP1CB;RAP1B;PPP1CC;ADCY9;PRKACA;PRKG1
GO_Biological_Process_2021,Rheumatoid arthritis,5/93,0.0198543028970904,0.3211739035781087,0,0,3.38111356728378,13.251715136207244,ATP6V1G1;TGFB2;CSF1;CTSL;ATP6V1E1
GO_Biological_Process_2021,Hippo signaling pathway,7/163,0.0198821940310257,0.3211739035781087,0,0,2.677213204736141,10.489135859118925,PPP1CB;PPP1CC;TGFB2;WWC1;CSNK1D;CTNNA3;NKD1
GO_Biological_Process_2021,cGMP-PKG signaling pathway,7/167,0.0223596646001947,0.3225098426843282,0,0,2.6097477064220183,9.91833736549238,PPP1CB;PPP1CC;ADCY9;CREB3L2;ATP2B4;MEF2D;PRKG1
GO_Biological_Process_2021,Protein processing in endoplasmic reticulum,7/171,0.025043071073348,0.3225098426843282,0,0,2.545573208025658,9.385930856750642,SEC13;SEC24A;SELENOS;OS9;HSPA4L;MARCHF6;HSPA1A
GO_Biological_Process_2021,Long-term potentiation,4/67,0.025720836078507,0.3225098426843282,0,0,3.771620971620972,13.805844593814816,PPP1CB;RAP1B;PPP1CC;PRKACA
GO_Biological_Process_2021,Autophagy,6/137,0.0276437008015138,0.3225098426843282,0,0,2.727843976913052,9.7884791099135,RHEB;CTSL;TSC2;WIPI1;PRKACA;SNAP29
GO_Biological_Process_2021,Insulin signaling pathway,6/137,0.0276437008015138,0.3225098426843282,0,0,2.727843976913052,9.7884791099135,PPP1CB;PPP1CC;PTPN1;RHEB;TSC2;PRKACA
GO_Biological_Process_2021,"Parathyroid hormone synthesis, secretion and action",5/106,0.0325821463840352,0.3601184600340741,0,0,2.9439646092268803,10.080107730334396,ADCY9;CREB3L2;PDE4B;PRKACA;MEF2D
GO_Biological_Process_2021,Vasopressin-regulated water reabsorption,3/44,0.0369490465554344,0.3879649888320617,0,0,4.338294893522954,14.308631181840134,ADCY9;CREB3L2;PRKACA
GO_Biological_Process_2021,Prion disease,9/273,0.0405352955650905,0.3972929790422324,0,0,2.035174825174825,6.523920171014376,SEM1;NDUFB9;TUBA1A;CAV2;CREB3L2;PSMB1;PRKACA;HSPA1A;SOD1
GO_Biological_Process_2021,Thermogenesis,8/232,0.0416211692329957,0.3972929790422324,0,0,2.1299298860648554,6.77135885574435,NDUFB9;ADCY9;KDM1A;RHEB;CREB3L2;TSC2;PRKACA;PRKG1
GO_Biological_Process_2021,Cellular senescence,6/156,0.0472479870718606,0.4236828506152238,0,0,2.38,7.264581641696578,PPP1CB;PPP1CC;TGFB2;RHEB;TSC2;ZFP36L2
GO_Biological_Process_2021,Human papillomavirus infection,10/331,0.0521792849949222,0.4236828506152238,0,0,1.8600246144379065,5.492782333931789,ATP6V1G1;HDAC2;CSNK1A1;RHEB;CREB3L2;HEY2;COL4A6;TSC2;ATP6V1E1;PRKACA
GO_Biological_Process_2021,Focal adhesion,7/201,0.0523507591814668,0.4236828506152238,0,0,2.148617547841988,6.33796806348736,VAV3;PPP1CB;RAP1B;PPP1CC;CAV2;COL4A6;PGF
GO_Biological_Process_2021,Thyroid hormone signaling pathway,5/121,0.0524559719809324,0.4236828506152238,0,0,2.561314327638612,7.550193940982165,HDAC2;RHEB;RCAN2;TSC2;PRKACA
GO_Biological_Process_2021,Endocrine and other factor-regulated calcium reabsorption,3/53,0.0586599695907139,0.447820077356389,0,0,3.555770392749245,10.084156775863704,ADCY9;ATP2B4;PRKACA
GO_Biological_Process_2021,Regulation of lipolysis in adipocytes,3/55,0.064142876805474,0.447820077356389,0,0,3.4186613990239367,9.38983978145378,ADCY9;PRKACA;PRKG1
GO_Biological_Process_2021,Oocyte meiosis,5/129,0.0654060549388453,0.447820077356389,0,0,2.3950877537013437,6.531740674399869,PPP1CB;PPP1CC;ADCY9;SPDYE3;PRKACA
GO_Biological_Process_2021,Relaxin signaling pathway,5/129,0.0654060549388453,0.447820077356389,0,0,2.3950877537013437,6.531740674399869,ACTA2;ADCY9;CREB3L2;COL4A6;PRKACA
GO_Biological_Process_2021,Morphine addiction,4/91,0.0661067733240383,0.447820077356389,0,0,2.7278300243817486,7.410106797384332,ADCY9;PDE4B;PDE7B;PRKACA
GO_Biological_Process_2021,Salivary secretion,4/93,0.0704211565775133,0.4621388400399311,0,0,2.6662580864828054,7.07428004030665,ADCY9;ATP2B4;PRKACA;PRKG1
GO_Biological_Process_2021,Collecting duct acid secretion,2/27,0.0742407618491795,0.4643819441780481,0,0,4.732771084337349,12.307296366080694,ATP6V1G1;ATP6V1E1
GO_Biological_Process_2021,Dilated cardiomyopathy,4/96,0.0771564487280274,0.4643819441780481,0,0,2.578919631093544,6.606986082465412,TGFB2;ADCY9;CACNA2D3;PRKACA
GO_Biological_Process_2021,Apelin signaling pathway,5/137,0.0799844104555405,0.4643819441780481,0,0,2.249009855392834,5.680826918793928,ACTA2;ADCY9;PRKACA;MEF2D;KLF2
GO_Biological_Process_2021,Aldosterone synthesis and secretion,4/98,0.0818196758789894,0.4643819441780481,0,0,2.523791102514507,6.317648600343242,ADCY9;CREB3L2;ATP2B4;PRKACA
GO_Biological_Process_2021,Inflammatory mediator regulation of TRP channels,4/98,0.0818196758789894,0.4643819441780481,0,0,2.523791102514507,6.317648600343242,PPP1CB;PPP1CC;ADCY9;PRKACA
GO_Biological_Process_2021,Amyotrophic lateral sclerosis,10/364,0.0857781098099488,0.4664093385880204,0,0,1.6837553184069192,4.135288641417113,SEM1;NDUFB9;SEC13;TUBA1A;PSMB1;NUP88;NUP153;WIPI1;NRG2;SOD1
GO_Biological_Process_2021,AGE-RAGE signaling pathway in diabetic complications,4/100,0.0866188771663466,0.4664093385880204,0,0,2.470959595959596,6.044554039527377,TGFB2;COL4A6;NOX4;F3
GO_Biological_Process_2021,Alcoholism,6/186,0.0923183496208256,0.4741800285769354,0,0,1.9802845528455284,4.718052409820051,PPP1CB;PPP1CC;HDAC2;CREB3L2;PRKACA;HDAC9
GO_Biological_Process_2021,Circadian rhythm,2/31,0.0942273958842767,0.4741800285769354,0,0,4.07914416285833,9.63511927131651,CRY1;CSNK1D
GO_Biological_Process_2021,Cortisol synthesis and secretion,3/65,0.094836005715387,0.4741800285769354,0,0,2.8658025533573728,6.75070207554272,ADCY9;CREB3L2;PRKACA
GO_Biological_Process_2021,Cell adhesion molecules,5/148,0.1026118056520312,0.4848497697314255,0,0,2.0748400535634577,4.724000581250202,CADM1;NRXN3;NRCAM;CD58;MPZL1
GO_Biological_Process_2021,Phospholipase D signaling pathway,5/148,0.1026118056520312,0.4848497697314255,0,0,2.0748400535634577,4.724000581250202,ADCY9;RHEB;TSC2;CYTH1;AGPAT4
GO_Biological_Process_2021,SNARE interactions in vesicular transport,2/33,0.1047357150685551,0.4848497697314255,0,0,3.8155849203264673,8.609161875414372,STX6;SNAP29
GO_Biological_Process_2021,Insulin resistance,4/108,0.1071275014703257,0.4848497697314255,0,0,2.27995337995338,5.092812920310519,PPP1CB;PPP1CC;PTPN1;CREB3L2
GO_Biological_Process_2021,Renal cell carcinoma,3/69,0.1085139960827476,0.4848497697314255,0,0,2.6915682504806373,5.977639647907784,RAP1B;TGFB2;ELOB
GO_Biological_Process_2021,Pathogenic Escherichia coli infection,6/197,0.113160382252064,0.4878671123656848,0,0,1.8651832460732984,4.064139457160408,TUBA1A;SEC24A;WIPF1;MYH11;CYTH1;WASF3
GO_Biological_Process_2021,Adherens junction,3/71,0.1156236182968876,0.4878671123656848,0,0,2.612137906522125,5.635465588023852,PTPN1;CTNNA3;WASF3
GO_Biological_Process_2021,Oxytocin signaling pathway,5/154,0.116158836277544,0.4878671123656848,0,0,1.9906774647600007,4.285523968924069,PPP1CB;PPP1CC;ADCY9;CACNA2D3;PRKACA
GO_Biological_Process_2021,Thyroid hormone synthesis,3/75,0.1303455976419415,0.526789866949058,0,0,2.466515609264854,5.025688128179551,ADCY9;CREB3L2;PRKACA
GO_Biological_Process_2021,Endocytosis,7/252,0.1304432051492905,0.526789866949058,0,0,1.6968982088248143,3.4562717240067653,WIPF1;CAV2;SMAP1;EPN1;CYTH1;SNX6;HSPA1A
GO_Biological_Process_2021,Arrhythmogenic right ventricular cardiomyopathy,3/77,0.1379423546356852,0.5414038513748803,0,0,2.3996080672817834,4.753430175575784,GJA1;CACNA2D3;CTNNA3
GO_Biological_Process_2021,Huntington disease,8/306,0.1417851446034606,0.5414038513748803,0,0,1.594927327376786,3.11559871947794,SEM1;NDUFB9;HDAC2;TUBA1A;CREB3L2;PSMB1;WIPI1;SOD1
GO_Biological_Process_2021,Synaptic vesicle cycle,3/78,0.1417962467886591,0.5414038513748803,0,0,2.367492447129909,4.624574832744028,ATP6V1G1;SYT1;ATP6V1E1
GO_Biological_Process_2021,Regulation of actin cytoskeleton,6/218,0.1588460858251549,0.5956728218443308,0,0,1.678612517257248,3.088344141681972,VAV3;PPP1CB;PPP1CC;TMSB4X;MYH11;SSH1
GO_Biological_Process_2021,Lysosome,4/128,0.1665700582892999,0.608407021282599,0,0,1.910263929618768,3.4238410906538053,AP3M1;LAPTM4A;CTSL;GLB1
GO_Biological_Process_2021,Purine metabolism,4/129,0.1698073072373996,0.608407021282599,0,0,1.8948848484848484,3.3598032171700787,NT5C3A;ADCY9;PDE4B;PDE7B
GO_Biological_Process_2021,Glycosphingolipid biosynthesis,2/45,0.1730268208215888,0.608407021282599,0,0,2.74908938077893,4.822751315649501,GLB1;ST3GAL2
GO_Biological_Process_2021,Insulin secretion,3/86,0.173830577509314,0.608407021282599,0,0,2.1384268190587123,3.741550119680159,ADCY9;CREB3L2;PRKACA
GO_Biological_Process_2021,Proteasome,2/46,0.1790125031003511,0.6084900857290388,0,0,2.686473165388828,4.621538781296302,SEM1;PSMB1
GO_Biological_Process_2021,Dopaminergic synapse,4/132,0.1796494538819067,0.6084900857290388,0,0,1.8501893939393936,3.176308581485773,PPP1CB;PPP1CC;CREB3L2;PRKACA
GO_Biological_Process_2021,Estrogen signaling pathway,4/137,0.1964603060257537,0.6468856164486135,0,0,1.7801777170198223,2.896874072000297,ADCY9;CREB3L2;PRKACA;HSPA1A
GO_Biological_Process_2021,Cocaine addiction,2/49,0.1971460926319584,0.6468856164486135,0,0,2.514611638041528,4.083252122746621,CREB3L2;PRKACA
GO_Biological_Process_2021,Ovarian steroidogenesis,2/51,0.2093562646266855,0.6536657849377345,0,0,2.411728546840423,3.771263008886746,ADCY9;PRKACA
GO_Biological_Process_2021,Circadian entrainment,3/97,0.2207010601773939,0.6536657849377345,0,0,1.8871247669859228,2.8513439239441207,ADCY9;PRKACA;PRKG1
GO_Biological_Process_2021,Phosphatidylinositol signaling system,3/97,0.2207010601773939,0.6536657849377345,0,0,1.8871247669859228,2.8513439239441207,INPP4B;PIP4P2;PPIP5K2
GO_Biological_Process_2021,Glycosaminoglycan biosynthesis,2/53,0.221640501400928,0.6536657849377345,0,0,2.316914717694307,3.490892098343502,CHST11;ST3GAL2
GO_Biological_Process_2021,MAPK signaling pathway,7/294,0.2222352071845686,0.6536657849377345,0,0,1.445438949802342,2.1739675949187323,RAP1B;TGFB2;CSF1;CACNA2D3;PRKACA;PGF;HSPA1A
GO_Biological_Process_2021,Choline metabolism in cancer,3/98,0.225086788640511,0.6536657849377345,0,0,1.867164891079663,2.78444553793939,RHEB;TSC2;WASF3
GO_Biological_Process_2021,Glycerophospholipid metabolism,3/98,0.225086788640511,0.6536657849377345,0,0,1.867164891079663,2.78444553793939,GNPAT;LPIN1;AGPAT4
GO_Biological_Process_2021,mRNA surveillance pathway,3/98,0.225086788640511,0.6536657849377345,0,0,1.867164891079663,2.78444553793939,PPP1CB;PPP1CC;RNMT
GO_Biological_Process_2021,Progesterone-mediated oocyte maturation,3/100,0.2339081028750608,0.6536657849377345,0,0,1.8284797707664997,2.65646471321379,ADCY9;SPDYE3;PRKACA
GO_Biological_Process_2021,Salmonella infection,6/249,0.2380359379427089,0.6536657849377345,0,0,1.462134899126769,2.0986513732334684,TUBA1A;CSE1L;RHOJ;PKN1;CYTH1;WASF3
GO_Biological_Process_2021,Melanogenesis,3/101,0.2383419607155901,0.6536657849377345,0,0,1.8097293297983843,2.5952402222314803,ADCY9;CREB3L2;PRKACA
GO_Biological_Process_2021,Gastric cancer,4/149,0.2385706018695838,0.6536657849377345,0,0,1.6318495297805642,2.3385872228062023,TGFB2;CSNK1A1;RARB;CTNNA3
GO_Biological_Process_2021,Amoebiasis,3/102,0.2427901486911585,0.6536657849377345,0,0,1.7913576856175044,2.5357703343976143,TGFB2;COL4A6;PRKACA
GO_Biological_Process_2021,Pancreatic secretion,3/102,0.2427901486911585,0.6536657849377345,0,0,1.7913576856175044,2.5357703343976143,RAP1B;ADCY9;ATP2B4
GO_Biological_Process_2021,Phagosome,4/152,0.2494184723138795,0.6598484929714128,0,0,1.5985257985257986,2.2197499799990488,ATP6V1G1;TUBA1A;CTSL;ATP6V1E1
GO_Biological_Process_2021,Viral carcinogenesis,5/203,0.2524180352694122,0.6598484929714128,0,0,1.494274047465537,2.057120304031302,HDAC2;DDX3X;CREB3L2;PRKACA;HDAC9
GO_Biological_Process_2021,Notch signaling pathway,2/59,0.2587608003723076,0.6598484929714128,0,0,2.0723948425280065,2.8015694437706533,HDAC2;HEY2
GO_Biological_Process_2021,Cushing syndrome,4/155,0.2603699648237209,0.6598484929714128,0,0,1.566526189042745,2.107998657199838,RAP1B;ADCY9;CREB3L2;PRKACA
GO_Biological_Process_2021,Other glycan degradation,1/18,0.2615985760079172,0.6598484929714128,0,0,3.470941529765059,4.6543385755323365,GLB1
GO_Biological_Process_2021,Glycerolipid metabolism,2/61,0.2711698827938793,0.6598484929714128,0,0,2.0019399632428017,2.6125512324612576,LPIN1;AGPAT4
GO_Biological_Process_2021,Glycosaminoglycan degradation,1/19,0.2739409696366148,0.6598484929714128,0,0,3.2779446112779445,4.244422438135941,GLB1
GO_Biological_Process_2021,Rap1 signaling pathway,5/210,0.2745684369375064,0.6598484929714128,0,0,1.4427311142412336,1.8648089319126693,VAV3;RAP1B;ADCY9;CSF1;PGF
GO_Biological_Process_2021,Pathways in cancer,11/531,0.2754883721679727,0.6598484929714128,0,0,1.2539056918313884,1.6165475783680547,TGFB2;HDAC2;ADCY9;SUFU;HEY2;COL4A6;RARB;ELOB;CTNNA3;PRKACA;PGF
GO_Biological_Process_2021,Alzheimer disease,8/369,0.2765079399118301,0.6598484929714128,0,0,1.3123056268375168,1.6869895424768373,SEM1;NDUFB9;TUBA1A;CSF1;CSNK1A1;PSMB1;NOX4;WIPI1
GO_Biological_Process_2021,Cholinergic synapse,3/113,0.2924323822587588,0.6802449793278414,0,0,1.6113155726448778,1.981147640647706,ADCY9;CREB3L2;PRKACA
GO_Biological_Process_2021,Glutamatergic synapse,3/114,0.2969897252545341,0.6802449793278414,0,0,1.596717563484935,1.9385073099650536,ADCY9;HOMER2;PRKACA
GO_Biological_Process_2021,Leukocyte transendothelial migration,3/114,0.2969897252545341,0.6802449793278414,0,0,1.596717563484935,1.9385073099650536,RAP1B;VAV3;CTNNA3
GO_Biological_Process_2021,Pantothenate and CoA biosynthesis,1/21,0.298012086181721,0.6802449793278414,0,0,2.94984984984985,3.5711508701847445,PANK2
GO_Biological_Process_2021,Histidine metabolism,1/22,0.3097475883868366,0.699430038292857,0,0,2.809237809237809,3.2924198134422538,ASPA
GO_Biological_Process_2021,"Growth hormone synthesis, secretion and action",3/119,0.319824975281074,0.7073947745132056,0,0,1.5275028648817586,1.7413248316031726,ADCY9;CREB3L2;PRKACA
GO_Biological_Process_2021,Human cytomegalovirus infection,5/225,0.3232131350605214,0.7073947745132056,0,0,1.343326885880077,1.517211567763341,ADCY9;RHEB;CREB3L2;TSC2;PRKACA
GO_Biological_Process_2021,AMPK signaling pathway,3/120,0.3243969202874953,0.7073947745132056,0,0,1.514369819505771,1.7048585379899075,RHEB;CREB3L2;TSC2
GO_Biological_Process_2021,Epithelial cell signaling in Helicobacter pylori infection,2/70,0.326749014894195,0.7073947745132056,0,0,1.7361800141743444,1.942026623356252,ATP6V1G1;ATP6V1E1
GO_Biological_Process_2021,Vitamin digestion and absorption,1/24,0.3326350097991272,0.7127893067124155,0,0,2.564695129912521,2.822984183281401,BTD
GO_Biological_Process_2021,Folate biosynthesis,1/26,0.354765724584809,0.7443262819037343,0,0,2.359279279279279,2.444915544744548,MOCS1
GO_Biological_Process_2021,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/26,0.354765724584809,0.7443262819037343,0,0,2.359279279279279,2.444915544744548,PIGL
GO_Biological_Process_2021,Chronic myeloid leukemia,2/76,0.3632039817820492,0.7443262819037343,0,0,1.5949202214262457,1.6153203184726643,HDAC2;TGFB2
GO_Biological_Process_2021,Gastric acid secretion,2/76,0.3632039817820492,0.7443262819037343,0,0,1.5949202214262457,1.6153203184726643,ADCY9;PRKACA
GO_Biological_Process_2021,Bacterial invasion of epithelial cells,2/77,0.3692109572888027,0.7443262819037343,0,0,1.573574297188755,1.5678891279827678,CAV2;CTNNA3
GO_Biological_Process_2021,FoxO signaling pathway,3/131,0.3745570751565141,0.7443262819037343,0,0,1.3834497734138973,1.3585630116703693,TGFB2;HOMER2;KLF2
GO_Biological_Process_2021,Antigen processing and presentation,2/78,0.3751955536739125,0.7443262819037343,0,0,1.5527901077996196,1.5222124290804273,CTSL;HSPA1A
GO_Biological_Process_2021,RNA transport,4/186,0.3768343613219099,0.7443262819037343,0,0,1.2976356976356975,1.2664269725370292,SEC13;STRAP;NUP88;NUP153
GO_Biological_Process_2021,PI3K-Akt signaling pathway,7/354,0.3792519626842837,0.7443262819037343,0,0,1.1918056914223267,1.155520554075081,CSF1;RHEB;CREB3L2;COL4A6;TSC2;PKN1;PGF
GO_Biological_Process_2021,Oxidative phosphorylation,3/133,0.3836156012780025,0.7459192247072272,0,0,1.362026493144318,1.3049770138965058,NDUFB9;ATP6V1G1;ATP6V1E1
GO_Biological_Process_2021,Pathways of neurodegeneration,9/475,0.3977971697036698,0.747362647124207,0,0,1.1409706173654672,1.0517615790367958,SEM1;NDUFB9;TUBA1A;CSF1;CSNK1A1;PSMB1;NOX4;WIPI1;SOD1
GO_Biological_Process_2021,Peroxisome,2/82,0.398892150735662,0.747362647124207,0,0,1.4748493975903614,1.3554812780853795,GNPAT;SOD1
GO_Biological_Process_2021,Chemokine signaling pathway,4/192,0.3994913486052751,0.747362647124207,0,0,1.2558349451966473,1.1523078927670705,RAP1B;VAV3;ADCY9;PRKACA
GO_Biological_Process_2021,Yersinia infection,3/137,0.4016391815882392,0.747362647124207,0,0,1.3210984353158677,1.2051075141353895,VAV3;WIPF1;PKN1
GO_Biological_Process_2021,Parkinson disease,5/249,0.4024854790372251,0.747362647124207,0,0,1.2097015297224576,1.1009448375543285,SEM1;NDUFB9;TUBA1A;PSMB1;PRKACA
GO_Biological_Process_2021,Galactose metabolism,1/31,0.4069436143572278,0.747362647124207,0,0,1.9655655655655653,1.7672019521539952,GLB1
GO_Biological_Process_2021,Fluid shear stress and atherosclerosis,3/139,0.4105963963691975,0.747362647124207,0,0,1.301537231206682,1.15855627419841,CAV2;CTSL;KLF2
GO_Biological_Process_2021,Ubiquitin mediated proteolysis,3/140,0.4150597256748963,0.747362647124207,0,0,1.291970802919708,1.136072370596502,ELOB;MID1;PIAS2
GO_Biological_Process_2021,Complement and coagulation cascades,2/85,0.4163877605406296,0.747362647124207,0,0,1.4213238496153289,1.245276312785813,A2M;F3
GO_Biological_Process_2021,Spinocerebellar ataxia,3/143,0.4283833005586381,0.7623770603162204,0,0,1.2640914976262407,1.0716170354806358,SEM1;PSMB1;WIPI1
GO_Biological_Process_2021,GABAergic synapse,2/89,0.4393091286032864,0.7659195105749104,0,0,1.3556986566957483,1.1151325714158156,ADCY9;PRKACA
GO_Biological_Process_2021,Diabetic cardiomyopathy,4/203,0.4406133674338822,0.7659195105749104,0,0,1.1857469164001828,0.9718233578578184,PPP1CB;PPP1CC;NDUFB9;TGFB2
GO_Biological_Process_2021,Bile secretion,2/90,0.4449627632863765,0.7659195105749104,0,0,1.340224534501643,1.0852664890643169,ADCY9;PRKACA
GO_Biological_Process_2021,Hypertrophic cardiomyopathy,2/90,0.4449627632863765,0.7659195105749104,0,0,1.340224534501643,1.0852664890643169,TGFB2;CACNA2D3
GO_Biological_Process_2021,Retrograde endocannabinoid signaling,3/148,0.450343000623421,0.7663724663801048,0,0,1.2201896030836543,0.9734010858617947,NDUFB9;ADCY9;PRKACA
GO_Biological_Process_2021,Mucin type O-glycan biosynthesis,1/36,0.4549136552007748,0.7663724663801048,0,0,1.6843414843414843,1.326667606598149,ST3GAL2
GO_Biological_Process_2021,Small cell lung cancer,2/92,0.4561740871310147,0.7663724663801048,0,0,1.3103078982597054,1.0284354751358575,COL4A6;RARB
GO_Biological_Process_2021,GnRH signaling pathway,2/93,0.4617307703448222,0.7672986494742585,0,0,1.295842711505362,1.0013926561424071,ADCY9;PRKACA
GO_Biological_Process_2021,"Alanine, aspartate and glutamate metabolism",1/37,0.4640329927772897,0.7672986494742585,0,0,1.6374708041374708,1.2572494679901522,ASPA
GO_Biological_Process_2021,Fc gamma R-mediated phagocytosis,2/97,0.4836204158638713,0.7872890490807207,0,0,1.2410272669625872,0.9015503946000128,VAV3;WASF3
GO_Biological_Process_2021,Prostate cancer,2/97,0.4836204158638713,0.7872890490807207,0,0,1.2410272669625872,0.9015503946000128,CREB3L2;ETV5
GO_Biological_Process_2021,Human T-cell leukemia virus 1 infection,4/219,0.4988105227886761,0.799946505850856,0,0,1.0966032417195208,0.762719322324167,TGFB2;ADCY9;CREB3L2;PRKACA
GO_Biological_Process_2021,Homologous recombination,1/41,0.4990142488879149,0.799946505850856,0,0,1.4734234234234234,1.0242070165090462,SEM1
GO_Biological_Process_2021,Hepatitis B,3/162,0.50984081547467,0.8111103882551567,0,0,1.1119534857208002,0.7490749474411187,TGFB2;DDX3X;CREB3L2
GO_Biological_Process_2021,Wnt signaling pathway,3/166,0.526218140087459,0.8193191264057975,0,0,1.0844438678108723,0.6962557305857052,CSNK1A1;PRKACA;NKD1
GO_Biological_Process_2021,Basal transcription factors,1/45,0.5317187458728566,0.8193191264057975,0,0,1.3392028392028392,0.8458948883694294,TAF7
GO_Biological_Process_2021,Glucagon signaling pathway,2/107,0.5358602645195618,0.8193191264057975,0,0,1.1222604704532415,0.7001579412072843,CREB3L2;PRKACA
GO_Biological_Process_2021,Tight junction,3/169,0.5383014158097924,0.8193191264057975,0,0,1.0646816874749754,0.6593963611766621,TUBA1A;MYH11;PRKACA
GO_Biological_Process_2021,Ras signaling pathway,4/232,0.5441131181051717,0.8193191264057975,0,0,1.0333864965443913,0.6289170749472998,RAP1B;CSF1;PRKACA;PGF
GO_Biological_Process_2021,HIF-1 signaling pathway,2/109,0.5458651068237136,0.8193191264057975,0,0,1.1011710392973764,0.6666306576869957,ELOB;ENO1
GO_Biological_Process_2021,TNF signaling pathway,2/112,0.5605885306838506,0.8193191264057975,0,0,1.070974808324206,0.6198460543855597,CSF1;CREB3L2
GO_Biological_Process_2021,Toxoplasmosis,2/112,0.5605885306838506,0.8193191264057975,0,0,1.070974808324206,0.6198460543855597,TGFB2;HSPA1A
GO_Biological_Process_2021,Sphingolipid metabolism,1/49,0.5622942507676832,0.8193191264057975,0,0,1.2273523523523524,0.7066235553727519,GLB1
GO_Biological_Process_2021,Serotonergic synapse,2/113,0.5654201699697972,0.8193191264057975,0,0,1.061272115488983,0.6051226728327782,KCND2;PRKACA
GO_Biological_Process_2021,Chemical carcinogenesis,4/239,0.5676197425870876,0.8193191264057975,0,0,1.0022437137330755,0.5675741747866299,ADCY9;CREB3L2;PRKACA;CYP3A5
GO_Biological_Process_2021,Cysteine and methionine metabolism,1/50,0.5696218688345068,0.8193191264057975,0,0,1.2022430593859166,0.6766013861906939,APIP
GO_Biological_Process_2021,Malaria,1/50,0.5696218688345068,0.8193191264057975,0,0,1.2022430593859166,0.6766013861906939,TGFB2
GO_Biological_Process_2021,N-Glycan biosynthesis,1/50,0.5696218688345068,0.8193191264057975,0,0,1.2022430593859166,0.6766013861906939,DPM1
GO_Biological_Process_2021,Pyrimidine metabolism,1/56,0.6110891254510002,0.87044598611616,0,0,1.0707616707616707,0.5273634669815475,NT5C3A
GO_Biological_Process_2021,Cell cycle,2/124,0.6160341805039481,0.87044598611616,0,0,0.9650404898281651,0.4675165955482397,TGFB2;HDAC2
GO_Biological_Process_2021,Legionellosis,1/57,0.6176021520538468,0.87044598611616,0,0,1.0515873015873016,0.5067712732922278,HSPA1A
GO_Biological_Process_2021,Endometrial cancer,1/58,0.6240064267250837,0.8736089974151171,0,0,1.0330857172962435,0.48719765741893,CTNNA3
GO_Biological_Process_2021,Osteoclast differentiation,2/127,0.6290308415499875,0.8736218677720232,0,0,0.941734939759036,0.4365647660469561,TGFB2;CSF1
GO_Biological_Process_2021,Long-term depression,1/60,0.6364959322339027,0.8736218677720232,0,0,0.997964065760676,0.4508574630639322,PRKG1
GO_Biological_Process_2021,Mineral absorption,1/60,0.6364959322339027,0.8736218677720232,0,0,0.997964065760676,0.4508574630639322,ATP2B4
GO_Biological_Process_2021,Steroid hormone biosynthesis,1/61,0.642584694498996,0.8762518561349946,0,0,0.9812812812812812,0.4339781728230409,CYP3A5
GO_Biological_Process_2021,Basal cell carcinoma,1/63,0.6544588478217535,0.8799906181867206,0,0,0.949530175336627,0.4025500622356348,SUFU
GO_Biological_Process_2021,Lysine degradation,1/63,0.6544588478217535,0.8799906181867206,0,0,0.949530175336627,0.4025500622356348,CAMKMT
GO_Biological_Process_2021,Epstein-Barr virus infection,3/202,0.658707483141207,0.8799906181867206,0,0,0.8866234495741547,0.3701437655781921,SEM1;HDAC2;CD58
GO_Biological_Process_2021,Inflammatory bowel disease,1/65,0.6659396545129517,0.8799906181867206,0,0,0.9197635135135136,0.3739355786231227,TGFB2
GO_Biological_Process_2021,Glycolysis / Gluconeogenesis,1/67,0.6770401068624523,0.8799906181867206,0,0,0.8918008918008918,0.3478244339493348,ENO1
GO_Biological_Process_2021,Fc epsilon RI signaling pathway,1/68,0.6824516428310011,0.8799906181867206,0,0,0.8784456097888934,0.335622098605308,VAV3
GO_Biological_Process_2021,Retinol metabolism,1/68,0.6824516428310011,0.8799906181867206,0,0,0.8784456097888934,0.335622098605308,CYP3A5
GO_Biological_Process_2021,Renin secretion,1/69,0.6877727692513288,0.8799906181867206,0,0,0.8654831301890126,0.3239475425887306,PRKACA
GO_Biological_Process_2021,Apoptosis,2/142,0.6889081492712751,0.8799906181867206,0,0,0.8401893287435456,0.3130943075776062,TUBA1A;CTSL
GO_Biological_Process_2021,RIG-I-like receptor signaling pathway,1/70,0.6930049920083694,0.8799906181867206,0,0,0.852896374635505,0.3127725178261643,DDX3X
GO_Biological_Process_2021,Lipid and atherosclerosis,3/215,0.6994678069314959,0.8799906181867206,0,0,0.8316992532634099,0.2972788458478658,VAV3;RAP1B;HSPA1A
GO_Biological_Process_2021,Non-small cell lung cancer,1/72,0.7032086261734348,0.8799906181867206,0,0,0.8287865330118851,0.2918171187495146,RARB
GO_Biological_Process_2021,Breast cancer,2/147,0.7070248690234295,0.8799906181867206,0,0,0.8110095554632323,0.2811684472249621,CSNK1A1;HEY2
GO_Biological_Process_2021,Inositol phosphate metabolism,1/73,0.7081829260645515,0.8799906181867206,0,0,0.8172339005672339,0.2819888852917578,INPP4B
GO_Biological_Process_2021,p53 signaling pathway,1/73,0.7081829260645515,0.8799906181867206,0,0,0.8172339005672339,0.2819888852917578,TSC2
GO_Biological_Process_2021,Spliceosome,2/150,0.7174677683651368,0.8822595563194165,0,0,0.7944480625203517,0.2637784090387538,SRSF10;HSPA1A
GO_Biological_Process_2021,Metabolism of xenobiotics by cytochrome P450,1/76,0.7226125889854269,0.8822595563194165,0,0,0.7844244244244244,0.2548454061584791,CYP3A5
GO_Biological_Process_2021,Pancreatic cancer,1/76,0.7226125889854269,0.8822595563194165,0,0,0.7844244244244244,0.2548454061584791,TGFB2
GO_Biological_Process_2021,Leishmaniasis,1/77,0.727262604769054,0.8828043179277534,0,0,0.774063537221432,0.2465141953848268,TGFB2
GO_Biological_Process_2021,RNA degradation,1/79,0.7363307652232398,0.8878867639809993,0,0,0.7541387541387541,0.2308236616514671,ENO1
GO_Biological_Process_2021,B cell receptor signaling pathway,1/81,0.7450982918193074,0.8878867639809993,0,0,0.7352102102102102,0.2163276155435562,VAV3
GO_Biological_Process_2021,JAK-STAT signaling pathway,2/162,0.7561551204150851,0.8878867639809993,0,0,0.7344126506024097,0.2052747532263637,FHL1;PIAS2
GO_Biological_Process_2021,ErbB signaling pathway,1/85,0.7617708673266889,0.8878867639809993,0,0,0.7000572000572001,0.1904921919697071,NRG2
GO_Biological_Process_2021,Colorectal cancer,1/86,0.7657662490530251,0.8878867639809993,0,0,0.6917859035506094,0.1846226553851083,TGFB2
GO_Biological_Process_2021,Taste transduction,1/86,0.7657662490530251,0.8878867639809993,0,0,0.6917859035506094,0.1846226553851083,PRKACA
GO_Biological_Process_2021,Calcium signaling pathway,3/240,0.7672886323601387,0.8878867639809993,0,0,0.7430112050174003,0.1968178987464413,ADCY9;ATP2B4;PRKACA
GO_Biological_Process_2021,Cardiac muscle contraction,1/87,0.7696948201955629,0.8878867639809993,0,0,0.6837069627767303,0.1789679414225768,CACNA2D3
GO_Biological_Process_2021,ECM-receptor interaction,1/88,0.7735576946892043,0.8878867639809993,0,0,0.675813744779262,0.1735185733306341,COL4A6
GO_Biological_Process_2021,Hepatocellular carcinoma,2/168,0.7737298943262995,0.8878867639809993,0,0,0.7076498766148933,0.1815351495395795,TGFB2;CSNK1A1
GO_Biological_Process_2021,Shigellosis,3/246,0.7815817034923728,0.8920225963771645,0,0,0.7244414605945321,0.1785281570017345,TNIP1;WIPI1;CYTH1
GO_Biological_Process_2021,TGF-beta signaling pathway,1/94,0.7954153962782357,0.902903963342862,0,0,0.6320191158900836,0.1446633545715099,TGFB2
GO_Biological_Process_2021,Axon guidance,2/182,0.8104953159553833,0.90482607456511,0,0,0.6521419009370817,0.1370213502672279,SLIT3;SSH1
GO_Biological_Process_2021,Hematopoietic cell lineage,1/99,0.8120139771383423,0.90482607456511,0,0,0.5996200281914568,0.1248635109811693,CSF1
GO_Biological_Process_2021,Viral protein interaction with cytokine and cytokine receptor,1/100,0.8151689336664037,0.90482607456511,0,0,0.5935329268662602,0.1212943335272886,CSF1
GO_Biological_Process_2021,Chagas disease,1/102,0.8213213452992933,0.90482607456511,0,0,0.5817203341955817,0.1145063186022207,TGFB2
GO_Biological_Process_2021,Protein digestion and absorption,1/103,0.8243205472558373,0.90482607456511,0,0,0.5759877524583407,0.1112784209961618,COL4A6
GO_Biological_Process_2021,Neutrophil extracellular trap formation,2/189,0.8268078452370677,0.90482607456511,0,0,0.6275046710907802,0.1193406973581439,HDAC2;HDAC9
GO_Biological_Process_2021,T cell receptor signaling pathway,1/104,0.8272695538881006,0.90482607456511,0,0,0.5703664829878422,0.1081555705130275,VAV3
GO_Biological_Process_2021,Transcriptional misregulation in cancer,2/192,0.8334049957736133,0.9068137259712892,0,0,0.6175015852885225,0.1125307506310848,HDAC2;ETV5
GO_Biological_Process_2021,Drug metabolism,1/108,0.8385801714436798,0.9077414226967668,0,0,0.5489321096797732,0.0966368022996464,CYP3A5
GO_Biological_Process_2021,Neurotrophin signaling pathway,1/119,0.8660189972146604,0.9278774970157077,0,0,0.4974805313788364,0.0715617953459406,RAP1B
GO_Biological_Process_2021,Sphingolipid signaling pathway,1/119,0.8660189972146604,0.9278774970157077,0,0,0.4974805313788364,0.0715617953459406,S1PR3
GO_Biological_Process_2021,Natural killer cell mediated cytotoxicity,1/131,0.8906742270837403,0.9474919511495264,0,0,0.4512820512820513,0.052247876509237,VAV3
GO_Biological_Process_2021,MicroRNAs in cancer,3/310,0.893349553940982,0.9474919511495264,0,0,0.5715283859984058,0.0644554493434089,TGFB2;HDAC2;PDCD4
GO_Biological_Process_2021,Measles,1/139,0.9045419797260232,0.9545417876505772,0,0,0.424946685816251,0.0426334405074484,HSPA1A
GO_Biological_Process_2021,Signaling pathways regulating pluripotency of stem cells,1/143,0.9108033686788216,0.9563435371127628,0,0,0.4128917650044411,0.0385757534772829,ZFHX3
GO_Biological_Process_2021,Neuroactive ligand-receptor interaction,3/341,0.9263223655580884,0.962946044580022,0,0,0.5182788394501153,0.0396654229996238,GLRB;GRID1;S1PR3
GO_Biological_Process_2021,Non-alcoholic fatty liver disease,1/155,0.9272352660314742,0.962946044580022,0,0,0.3804843804843805,0.0287448159807004,NDUFB9
GO_Biological_Process_2021,Ribosome,1/158,0.930847843094021,0.962946044580022,0,0,0.3731565960865324,0.026740196030022,RPS21
GO_Biological_Process_2021,Tuberculosis,1/180,0.952408900934086,0.9764598988735352,0,0,0.3269246900531817,0.01594111551383,TGFB2
GO_Biological_Process_2021,NOD-like receptor signaling pathway,1/181,0.9532108536622608,0.9764598988735352,0,0,0.3250917584250917,0.0155781198480525,PKN1
GO_Biological_Process_2021,Cytokine-cytokine receptor interaction,2/295,0.959205735163658,0.977831089244506,0,0,0.3983099634031004,0.0165894889593355,TGFB2;CSF1
GO_Biological_Process_2021,Herpes simplex virus 1 infection,4/498,0.9683876775171136,0.98173365682047,0,0,0.4704208072629125,0.0151112234305638,PPP1CB;PPP1CC;RHEB;TSC2
GO_Biological_Process_2021,Human immunodeficiency virus 1 infection,1/212,0.972383812469799,0.98173365682047,0,0,0.2768882626702532,0.0077541682068463,ELOB
GO_Biological_Process_2021,Coronavirus disease,1/232,0.9803552039741028,0.9850458987299596,0,0,0.2526552526552527,0.0050127610504747,RPS21
GO_Biological_Process_2021,Olfactory transduction,2/440,0.9951844234588272,0.9951844234588272,0,0,0.264455080596358,0.0012765798893228,PRKACA;PRKG1
